{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:48Z","timestamp":1793830968890,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T00:00:00Z","timestamp":1320192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-304","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T19:45:46Z","timestamp":1320263146000},"source":"Crossref","is-referenced-by-count":45,"title":["Risk of infections in bronchiectasis during disease-modifying treatment and biologics for rheumatic diseases"],"prefix":"10.1186","volume":"11","author":[{"given":"Guillaume","family":"Geri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Dadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tach","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Del Castillo Pinol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Paternotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,2]]},"reference":[{"issue":"19","key":"1648_CR1","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V: Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295 (19): 2275-2285. 10.1001\/jama.295.19.2275.","journal-title":"JAMA"},{"issue":"8","key":"1648_CR2","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP: Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006, 54 (8): 2368-2376. 10.1002\/art.21978.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1648_CR3","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A: Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005, 52 (11): 3403-3412. 10.1002\/art.21386.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1648_CR4","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantap\u00e4\u00e4-Dahlqvist S, Saxne T, van Vollenhoven RF, Klareskog L: Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007, 66 (10): 1339-1344. 10.1136\/ard.2006.062760.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1648_CR5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1136\/ard.2008.091025","volume":"68","author":"JP Leombruno","year":"2009","unstructured":"Leombruno JP, Einarson TR, Keystone EC: The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis. 2009, 68 (7): 1136-1145. 10.1136\/ard.2008.091025.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1648_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2007.083188","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, Dougados M, Gossec L: Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials. Ann Rheum Dis. 2009, 68 (1): 25-32.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1648_CR7","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE: Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002, 46 (9): 2287-2293. 10.1002\/art.10524.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1648_CR8","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE: Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002, 46 (9): 2294-2300. 10.1002\/art.10529.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1648_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1445-5994.2006.01219.x","volume":"36","author":"P King","year":"2006","unstructured":"King P, Holdsworth S, Freezer N, Holmes P: Bronchiectasis. Intern Med J. 2006, 36 (11): 729-737. 10.1111\/j.1445-5994.2006.01219.x.","journal-title":"Intern Med J"},{"issue":"3","key":"1648_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/thx.2006.060913","volume":"63","author":"AB Chang","year":"2008","unstructured":"Chang AB, Bilton D: Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis. Thorax. 2008, 63 (3): 269-276. 10.1136\/thx.2006.060913.","journal-title":"Thorax"},{"issue":"1","key":"1648_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1081\/COPD-200050685","volume":"2","author":"PT King","year":"2005","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Gallagher M, Holmes PW: Outcome in adult bronchiectasis. COPD. 2005, 2 (1): 27-34. 10.1081\/COPD-200050685.","journal-title":"COPD"},{"issue":"18","key":"1648_CR12","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMra012519","volume":"346","author":"AF Barker","year":"2002","unstructured":"Barker AF: Bronchiectasis. N Engl J Med. 2002, 346 (18): 1383-1393. 10.1056\/NEJMra012519.","journal-title":"N Engl J Med"},{"key":"1648_CR13","doi-asserted-by":"crossref","unstructured":"Management of bronchiectasis. Drug Ther Bull. 2003, 41 (12): 91-95.","DOI":"10.1136\/dtb.2003.411291"},{"issue":"4","key":"1648_CR14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/ard.54.4.308","volume":"54","author":"WU Hassan","year":"1995","unstructured":"Hassan WU, Keaney NP, Holland CD, Kelly CA: High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis. 1995, 54 (4): 308-310. 10.1136\/ard.54.4.308.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1648_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.semarthrit.2006.02.003","volume":"35","author":"L Lieberman-Maran","year":"2006","unstructured":"Lieberman-Maran L, Orzano IM, Passero MA, Lally EV: Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature--implications for management with biologic response modifiers. Semin Arthritis Rheum. 2006, 35 (6): 379-387. 10.1016\/j.semarthrit.2006.02.003.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"1648_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2321030174","volume":"232","author":"N Tanaka","year":"2004","unstructured":"Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, Emoto T, Matsumoto T, Lynch DA: Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004, 232 (1): 81-91. 10.1148\/radiol.2321030174.","journal-title":"Radiology"},{"issue":"10","key":"1648_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1136\/ard.54.10.815","volume":"54","author":"B Cortet","year":"1995","unstructured":"Cortet B, Flipo RM, Remy-Jardin M, Coquerelle P, Duquesnoy B, Remy J, Delcambre B: Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis. 1995, 54 (10): 815-819. 10.1136\/ard.54.10.815.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1648_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jbspin.2004.02.001","volume":"72","author":"SH Zrour","year":"2005","unstructured":"Zrour SH, Touzi M, Bejia I, Golli M, Rouatbi N, Sakly N, Younes M, Tabka Z, Bergaoui N: Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine. 2005, 72 (1): 41-47.","journal-title":"Joint Bone Spine"},{"issue":"2","key":"1648_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1148\/radiology.193.2.7972746","volume":"193","author":"M Remy-Jardin","year":"1994","unstructured":"Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B: Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994, 193 (2): 375-382.","journal-title":"Radiology"},{"issue":"3","key":"1648_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31 (3): 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1648_CR21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25 (11): 1271-1277. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1648_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40 (9): 1725-","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1648_CR23","first-page":"85","volume":"57","author":"B Amor","year":"1990","unstructured":"Amor B, Dougados M, Mijiyawa M: [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic. 1990, 57 (2): 85-89.","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"5","key":"1648_CR24","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","volume":"113","author":"AE O'Donnell","year":"1998","unstructured":"O'Donnell AE, Barker AF, Ilowite JS, Fick RB: Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest. 1998, 113 (5): 1329-1334. 10.1378\/chest.113.5.1329.","journal-title":"Chest"},{"issue":"4","key":"1648_CR25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/jcm.6.4.396-399.1977","volume":"6","author":"RW Geckler","year":"1977","unstructured":"Geckler RW, Gremillion DH, McAllister CK, Ellenbogen C: Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates. J Clin Microbiol. 1977, 6 (4): 396-399.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"1648_CR26","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/art.21778","volume":"54","author":"P Emery","year":"2006","unstructured":"Emery P, Fleischmann R, Filipowicz-Sosnowska A, Schechtman J, Szczepanski L, Kavanaugh A, Racewicz AJ, van Vollenhoven RF, Li NF, Agarwal S, et al: The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum. 2006, 54 (5): 1390-1400. 10.1002\/art.21778.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1648_CR27","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/art.22025","volume":"54","author":"SB Cohen","year":"2006","unstructured":"Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, et al: Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 2006, 54 (9): 2793-2806. 10.1002\/art.22025.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"1648_CR28","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/art.24632","volume":"60","author":"F Tubach","year":"2009","unstructured":"Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, et al: Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum. 2009, 60 (7): 1884-1894. 10.1002\/art.24632.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1648_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1136\/thorax.57.9.759","volume":"57","author":"IS Patel","year":"2002","unstructured":"Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002, 57 (9): 759-764. 10.1136\/thorax.57.9.759.","journal-title":"Thorax"},{"issue":"5","key":"1648_CR30","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1378\/chest.07-0490","volume":"132","author":"MA Martinez-Garcia","year":"2007","unstructured":"Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, Roman-Sanchez P, Soriano J: Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007, 132 (5): 1565-1572. 10.1378\/chest.07-0490.","journal-title":"Chest"},{"issue":"2","key":"1648_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpeds.2008.08.001","volume":"154","author":"SD Sagel","year":"2009","unstructured":"Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW: Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr. 2009, 154 (2): 183-188. 10.1016\/j.jpeds.2008.08.001.","journal-title":"J Pediatr"},{"issue":"8","key":"1648_CR32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","volume":"178","author":"EC Dasenbrook","year":"2008","unstructured":"Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP: Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008, 178 (8): 814-821. 10.1164\/rccm.200802-327OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1648_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000085362","volume":"72","author":"B Karadag","year":"2005","unstructured":"Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E: Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005, 72 (3): 233-238. 10.1159\/000085362.","journal-title":"Respiration"},{"issue":"11","key":"1648_CR34","first-page":"996","volume":"86","author":"O Bouyahia","year":"2008","unstructured":"Bouyahia O, Essadem L, Matoussi N, Gharsallah L, Fitouri Z, Mrad Mazigh S, Boukthir S, Bellagah I, Ben Becher S, Sammoud El Gharbi A: Etiology and outcome of bronchiectasis in children: a study of 41 patients. Tunis Med. 2008, 86 (11): 996-999.","journal-title":"Tunis Med"},{"issue":"6","key":"1648_CR35","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/art.23721","volume":"59","author":"KG Saag","year":"2008","unstructured":"Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, et al: American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008, 59 (6): 762-784. 10.1002\/art.23721.","journal-title":"Arthritis Rheum"},{"key":"1648_CR36","doi-asserted-by":"crossref","unstructured":"Chang CC, Singleton RJ, Morris PS, Chang AB: Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev. 2009, CD006316-2","DOI":"10.1002\/14651858.CD006316.pub3"},{"key":"1648_CR37","doi-asserted-by":"crossref","unstructured":"Lee AL, Cecins N, Hill CJ, Holland AE, Rautela L, Stirling RG, Thompson PJ, McDonald CF, Jenkins S: The effects of pulmonary rehabilitation in patients with non-cystic fibrosis bronchiectasis: protocol for a randomised controlled trial. BMC Pulm Med. 10: 5-","DOI":"10.1186\/1471-2466-10-5"},{"issue":"5","key":"1648_CR38","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.00055509","volume":"34","author":"MP Murray","year":"2009","unstructured":"Murray MP, Pentland JL, Hill AT: A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J. 2009, 34 (5): 1086-1092. 10.1183\/09031936.00055509.","journal-title":"Eur Respir J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-304\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T04:21:33Z","timestamp":1639455693000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1648"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-304","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,2]]},"article-number":"304"}}